Rudy J. Richardson

Affiliations: 
University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
Toxicology, Biochemistry
Google:
"Rudy Richardson"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Makhaeva GF, Kovaleva NV, Boltneva NP, et al. (2020) New Hybrids of 4-Amino-2,3-polymethylene-quinoline and -Tolylsulfonamide as Dual Inhibitors of Acetyl- and Butyrylcholinesterase and Potential Multifunctional Agents for Alzheimer's Disease Treatment. Molecules (Basel, Switzerland). 25
Talley TT, Chao CK, Berkman CE, et al. (2020) Inhibition of acetylcholinesterases by stereoisomeric organophosphorus compounds containing both thioester and p-nitrophenyl leaving groups. Chemical Research in Toxicology
Richardson RJ, Fink JK, Glynn P, et al. (2020) Neuropathy target esterase (NTE/PNPLA6) and organophosphorus compound-induced delayed neurotoxicity (OPIDN). Advances in Neurotoxicology. 4: 1-78
Makhaeva GF, Kovaleva NV, Boltneva NP, et al. (2019) Conjugates of tacrine and 1,2,4-thiadiazole derivatives as new potential multifunctional agents for Alzheimer's disease treatment: Synthesis, quantum-chemical characterization, molecular docking, and biological evaluation. Bioorganic Chemistry. 103387
Khudina OG, Makhaeva GF, Elkina NA, et al. (2019) Synthesis of 2-arylhydrazinylidene-3-oxo-4,4,4-trifluorobutanoic acids as new selective carboxylesterase inhibitors and radical scavengers. Bioorganic & Medicinal Chemistry Letters. 126716
Makhaeva GF, Elkina NA, Shchegolkov EV, et al. (2019) Synthesis, molecular docking, and biological evaluation of 3-oxo-2-tolylhydrazinylidene-4,4,4-trifluorobutanoates bearing higher and natural alcohol moieties as new selective carboxylesterase inhibitors. Bioorganic Chemistry. 91: 103097
Makhaeva GF, Shevtsova EF, Boltneva NP, et al. (2019) Overview of novel multifunctional agents based on conjugates of γ-carbolines, carbazoles, tetrahydrocarbazoles, phenothiazines, and aminoadamantanes for treatment of Alzheimer's disease. Chemico-Biological Interactions
Bachurin SO, Makhaeva GF, Shevtsova EF, et al. (2019) Conjugates of methylene blue with γ-carboline derivatives as new multifunctional agents for the treatment of neurodegenerative diseases. Scientific Reports. 9: 4873
Makhaeva GF, Boltneva NP, Lushchekina SV, et al. (2018) Synthesis, molecular docking, and biological activity of 2-vinyl chromones: Toward selective butyrylcholinesterase inhibitors for potential Alzheimer's disease therapeutics. Bioorganic & Medicinal Chemistry
Makhaeva GF, Lushchekina SV, Boltneva NP, et al. (2017) 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment. Bioorganic & Medicinal Chemistry
See more...